Development of an ADP-ribosylation assay for residual toxicity in C. difficile binary toxin CDTa using automated

Richard R Rustandi1, Melissa Hamm1

  • 1Vaccine Research Analytical Development, Merck & Co., Inc., Kenilworth, NJ, USA.

Related Concept Videos